Growth Metrics

Merck (MRK) EBIT (2009 - 2026)

Merck (MRK) reported EBIT of -$7.7 billion for Q1 2026, down 411.15% year-over-year from $2.5 billion in Q1 2025, and down 262.69% on a QoQ basis from -$2.1 billion in Q4 2025.

Merck (MRK) has 18 years of EBIT data on file, last reported at -$7.7 billion in Q1 2026.

  • Quarterly EBIT fell 411.15% year-over-year to -$7.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.5 billion (down 208.46% YoY) and the FY2025 annual result came in at $4.7 billion, down 1.22% from the prior year.
  • EBIT eased to -$7.7 billion in Q1 2026 per MRK's latest filing, from -$2.1 billion in the prior quarter.
  • Across five years, EBIT topped out at $2.9 billion in Q3 2025 and bottomed at -$9.4 billion in Q2 2023.
  • The 5-year median for EBIT is $10.0 million (2024), against an average of -$794.4 million.
  • The widest annual swing landed in 2023, when EBIT plunged 3553.51%; it then surged 28800.0% in 2025.
  • Tracing MRK's EBIT over 5 years: stood at -$368.0 million in 2022, then tumbled by 1519.02% to -$6.0 billion in 2023, then surged by 105.74% to $342.0 million in 2024, then sank by 723.1% to -$2.1 billion in 2025, then plunged by 262.69% to -$7.7 billion in 2026.
  • Per Business Quant, the three latest MRK EBIT figures stand at -$7.7 billion (Q1 2026), -$2.1 billion (Q4 2025), and $2.9 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 9.50 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 6.36 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 3.99 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -7.73 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 2.67 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 2.59 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -6.71 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -182.00 Mn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.73 Bn
Dec 31, 2025 -2.13 Bn
Sep 30, 2025 2.89 Bn
Jun 30, 2025 1.44 Bn
Mar 31, 2025 2.48 Bn
Dec 31, 2024 342.00 Mn
Sep 30, 2024 10.00 Mn
Jun 30, 2024 2.26 Bn
Mar 31, 2024 2.13 Bn
Dec 31, 2023 -5.96 Bn
Sep 30, 2023 1.36 Bn
Jun 30, 2023 -9.36 Bn
Mar 31, 2023 -276.00 Mn
Dec 31, 2022 -368.00 Mn
Sep 30, 2022 -351.00 Mn
Jun 30, 2022 271.00 Mn
Mar 31, 2022 -519.00 Mn
Dec 31, 2021 35.00 Mn
Sep 30, 2021 1.82 Bn
Jun 30, 2021 -1.39 Bn
Mar 31, 2021 -212.00 Mn
Dec 31, 2020 -7.57 Bn
Sep 30, 2020 -307.00 Mn
Jun 30, 2020 -6.00 Mn
Mar 31, 2020 526.00 Mn
Dec 31, 2019 -3.08 Bn
Sep 30, 2019 -1.64 Bn
Jun 30, 2019 -142.00 Mn
Mar 31, 2019 15.00 Mn
Dec 31, 2018 -685.00 Mn
Sep 30, 2018 -954.00 Mn
Jun 30, 2018 -1.33 Bn
Mar 31, 2018 -1.84 Bn
Dec 31, 2017 -1.56 Bn
Sep 30, 2017 -3.11 Bn
Jun 30, 2017 -677.00 Mn
Mar 31, 2017 -1.05 Bn
Dec 31, 2016 -4.83 Bn
Sep 30, 2016 -522.00 Mn
Jun 30, 2016 -2.07 Bn
Mar 31, 2016 -1.95 Bn
Dec 31, 2015 -3.03 Bn
Sep 30, 2015 -1.36 Bn
Jun 30, 2015 -2.95 Bn
Mar 31, 2015 -2.19 Bn
Dec 31, 2014 8.06 Bn
Sep 30, 2014 -2.73 Bn
Jun 30, 2014 -3.00 Bn
Mar 31, 2014 -1.81 Bn
Dec 31, 2013 -3.38 Bn
Sep 30, 2013 -2.58 Bn
Jun 30, 2013 -3.04 Bn
Mar 31, 2013 -2.41 Bn
Dec 31, 2012 -2.83 Bn
Sep 30, 2012 -1.92 Bn
Jun 30, 2012 -1.43 Bn
Mar 31, 2012 -1.53 Bn
Dec 31, 2011 -2.60 Bn
Sep 30, 2011 -2.00 Bn
Jun 30, 2011 -2.61 Bn
Mar 31, 2011 -2.33 Bn
Dec 31, 2010 -5.14 Bn
Sep 30, 2010 -3.69 Bn
Jun 30, 2010 -3.31 Bn
Mar 31, 2010 645.00 Mn
Dec 31, 2009 -1.72 Bn
Sep 30, 2009 1.60 Bn
Jun 30, 2009 1.38 Bn
Mar 31, 2009 1.13 Bn